Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value.

Fabisiewicz A, Szostakowska-Rodzos M, Zaczek AJ, Grzybowska EA.

Int J Mol Sci. 2020 Feb 29;21(5). pii: E1671. doi: 10.3390/ijms21051671. Review.

2.

NF-kappa B Signaling-Related Signatures Are Connected with the Mesenchymal Phenotype of Circulating Tumor Cells in Non-Metastatic Breast Cancer.

Popeda M, Stokowy T, Bednarz-Knoll N, Jurek A, Niemira M, Bielska A, Kretowski A, Kalinowski L, Szade J, Markiewicz A, Zaczek AJ.

Cancers (Basel). 2019 Dec 6;11(12). pii: E1961. doi: 10.3390/cancers11121961.

3.

Liquid biopsy for minimally invasive heart transplant monitoring: a pilot study.

Bieńkowski M, Pęksa R, Popęda M, Kołaczkowska M, Frankiewicz A, Żaczek AJ, Gruchała M, Biernat W, Siondalski P.

J Clin Pathol. 2019 Dec 5. pii: jclinpath-2019-205926. doi: 10.1136/jclinpath-2019-205926. [Epub ahead of print]

PMID:
31806731
4.

High-grade non-small cell lung carcinoma: a comparative analysis of the phenotypic profile in small biopsies with the corresponding postoperative material.

Szade J, Majewska HI, Żaczek AJ, Biernat W.

Pol J Pathol. 2019;70(2):100-108. doi: 10.5114/pjp.2019.84087.

5.

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy.

Smentoch J, Szade J, Żaczek AJ, Eltze E, Semjonow A, Brandt B, Bednarz-Knoll N.

Cancers (Basel). 2019 Sep 12;11(9). pii: E1356. doi: 10.3390/cancers11091356.

6.

Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients.

Markiewicz A, Topa J, Nagel A, Skokowski J, Seroczynska B, Stokowy T, Welnicka-Jaskiewicz M, Zaczek AJ.

Cancers (Basel). 2019 Jan 9;11(1). pii: E59. doi: 10.3390/cancers11010059.

7.

Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients.

Markiewicz A, Nagel A, Szade J, Majewska H, Skokowski J, Seroczynska B, Stokowy T, Welnicka-Jaskiewicz M, Zaczek AJ.

Transl Oncol. 2018 Jun;11(3):722-731. doi: 10.1016/j.tranon.2018.03.006. Epub 2018 Apr 16.

8.

MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma.

Filipska M, Skrzypski M, Czetyrbok K, Stokowy T, Stasiłojć G, Supernat A, Jassem J, Żaczek AJ, Bigda J.

Lung Cancer. 2018 Apr;118:111-118. doi: 10.1016/j.lungcan.2018.02.002. Epub 2018 Feb 6.

PMID:
29571988
9.

RSK1 promotes murine breast cancer growth and metastasis.

Czaplinska D, Gorska M, Mieczkowski K, Peszynska-Sularz G, Zaczek AJ, Romanska HM, Sadej R.

Folia Histochem Cytobiol. 2018;56(1):11-20. doi: 10.5603/FHC.a2018.0001. Epub 2018 Mar 2.

10.

The Landscape of Circulating Tumor Cell Research in the Context of Epithelial-Mesenchymal Transition.

Markiewicz A, Żaczek AJ.

Pathobiology. 2017;84(5):264-283. doi: 10.1159/000477812. Epub 2017 Oct 14. Review.

11.

Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells.

Piasecka D, Kitowska K, Czaplinska D, Mieczkowski K, Mieszkowska M, Turczyk L, Skladanowski AC, Zaczek AJ, Biernat W, Kordek R, Romanska HM, Sadej R.

Oncotarget. 2016 Dec 27;7(52):86011-86025. doi: 10.18632/oncotarget.13322.

12.

Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.

Czaplinska D, Mieczkowski K, Supernat A, Skladanowski AC, Kordek R, Biernat W, Zaczek AJ, Romanska HM, Sadej R.

Tumour Biol. 2016 Oct;37(10):13721-13731. Epub 2016 Jul 30.

13.

Immunohistochemical characterisation of molecular subtypes in endometrial cancer.

Łapińska-Szumczyk SM, Supernat AM, Majewska HI, Gulczyński J, Biernat W, Wydra D, Żaczek AJ.

Int J Clin Exp Med. 2015 Nov 15;8(11):21981-90. eCollection 2015.

14.

HOTAIR in relation to epithelial-mesenchymal transition and cancer stem cells in molecular subtypes of endometrial cancer.

Łuczak A, Supernat A, Łapińska-Szumczyk S, Jachimowicz D, Majewska H, Gulczyński J, Żaczek AJ.

Int J Biol Markers. 2016 Jul 30;31(3):e245-51. doi: 10.5301/jbm.5000187.

PMID:
26868332
15.

Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.

Markiewicz A, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Majewska H, Szade J, Żaczek AJ.

Am J Transl Res. 2014 Nov 22;6(6):793-808. eCollection 2014.

16.

[Endometrial cancer in young women--clinical and molecular aspects].

Lapińska-Szumczyk S, Supernat A, Żaczek AJ, Majewska H, Gulczyński J, Sawicki S, Biernat W, Wydra D.

Ginekol Pol. 2014 Oct;85(10):754-9. Polish.

PMID:
25546926
17.

HER2-positive endometrial cancer subtype carries poor prognosis.

Lapińska-Szumczyk S, Supernat A, Majewska H, Gulczyński J, Luczak A, Biernat W, Wydra D, Zaczek AJ.

Clin Transl Sci. 2014 Dec;7(6):482-8. doi: 10.1111/cts.12207. Epub 2014 Sep 9.

18.

Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.

Supernat A, Lapińska-Szumczyk S, Majewska H, Gulczyński J, Biernat W, Wydra D, Zaczek AJ.

Transl Oncol. 2014 Oct;7(5):613-9. doi: 10.1016/j.tranon.2014.06.001. Epub 2014 Jul 19.

19.

Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.

Czaplinska D, Turczyk L, Grudowska A, Mieszkowska M, Lipinska AD, Skladanowski AC, Zaczek AJ, Romanska HM, Sadej R.

Biochim Biophys Acta. 2014 Nov;1843(11):2461-70. doi: 10.1016/j.bbamcr.2014.06.022. Epub 2014 Jul 8.

20.

Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.

Markiewicz A, Książkiewicz M, Wełnicka-Jaśkiewicz M, Seroczyńska B, Skokowski J, Szade J, Żaczek AJ.

PLoS One. 2014 Apr 7;9(4):e93901. doi: 10.1371/journal.pone.0093901. eCollection 2014.

Supplemental Content

Loading ...
Support Center